Skip to main content
SpringerLink
Log in

The Epidemiology of Vitamin D and Cancer Risk

  • Chapter
  • First Online:
Vitamin D

Part of the book series: Nutrition and Health ((NH))

Abstract

The relation between vitamin D status and cancer risk has been investigated in a number of epidemiologic studies, while data from interventional studies remain scarce. The approaches to estimate vitamin D status have been varied and include direct measures of circulating 25-hydroxyvitamin D [25(OH)D] levels, surrogates or determinants of 25(OH)D, including region of residence, intake, and sun exposure estimates. In terms of cancer sites, the body of evidence is most extensive for colorectal cancer, for which support comes from studies of 25(OH)D, vitamin D intake, multiple predictors of 25(OH)D, and region of residence in a sunny climate. The evidence for breast cancer is also intriguing but prospective studies of 25(OH)D are sparse and somewhat conflicting. In one case–control study, retrospectively reported sun exposure during ages 10–19 was most strongly associated with reduced risk of breast cancer. For prostate cancer, the data on circulating 25(OH)D have been equivocal, suggesting no association or a weak inverse association, but studies tend to support a benefit of sun exposure on prostate cancer risk. It is plausible that for prostate cancer, vitamin D level much longer before the time of diagnosis is the most relevant exposure. Most of the epidemiologic studies to date have examined vitamin D status in relation to risk of cancer, but emerging evidence suggests that vitamin D may be an important factor for cancer progression and mortality, independently of any effects on incidence. Further study is needed to establish the precise role of vitamin D on carcinogenesis, especially in terms of when in the life span and on what stages of carcinogenesis vitamin D is relevant, the precise intakes and levels required, the magnitude of the association, and which cancer sites are most affected.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Peller S, Stephenson CS (1937) Skin irritation and cancer in the United States Navy. Am J Med Sci 194:326–333

    Article  Google Scholar 

  2. Apperly FL (1941) The relation of solar radiation to cancer mortality in North America. Cancer Res 1:191–195

    Google Scholar 

  3. Garland CF, Garland FC (1980) Do sunlight and vitamin D reduce the likelihood of colon cancer? Int J Epidemiol 9:227–231

    Article  PubMed  CAS  Google Scholar 

  4. Garland FC, Garland CF, Gorham ED et al (1990) Geographic variation in breast cancer mortality in the United States: a hypothesis involving exposure to solar radiation. Prev Med 19:614–622

    Article  PubMed  CAS  Google Scholar 

  5. Lefkowitz ES, Garland CF (1994) Sunlight, vitamin D, and ovarian cancer mortality rates in US women. Int J Epidemiol 23:1133–1136

    Article  PubMed  CAS  Google Scholar 

  6. Schwartz GG, Hulka BS (1990) Is vitamin D deficiency a risk factor for prostate cancer? (Hypothesis). Anticancer Res 10:1307–1311

    PubMed  CAS  Google Scholar 

  7. Hanchette CL, Schwartz GG (1992) Geographic patterns of prostate cancer mortality. Cancer 70:2861–2869

    Article  PubMed  CAS  Google Scholar 

  8. Grant WB (2002) An estimate of premature cancer mortality in the U.S. due to inadequate doses of solar ultraviolet-B radiation. Cancer 94:1867–1875

    Article  PubMed  Google Scholar 

  9. Jacobs ET, Haussler MR, Martinez ME (2005) Vitamin D activity and colorectal neoplasia: a pathway approach to epidemiologic studies. Cancer Epidemiol Biomarkers Prev 14:2061–2063

    Article  PubMed  CAS  Google Scholar 

  10. Garland CF, Comstock GW, Garland FC et al (1989) Serum 25-hydroxyvitamin D and colon cancer: eight-year prospective study. Lancet 2:1176–1178

    Article  PubMed  CAS  Google Scholar 

  11. Tangrea J, Helzlsouer K, Pietinen P et al (1997) Serum levels of vitamin D metabolites and the subsequent risk of colon and rectal cancer in Finnish men. Cancer Causes Control 8:615–625

    Article  PubMed  CAS  Google Scholar 

  12. Feskanich D, Ma J, Fuchs CS et al (2004) Plasma vitamin D metabolites and risk of colorectal cancer in women. Cancer Epidemiol Biomarkers Prev 13:1502–1508

    PubMed  CAS  Google Scholar 

  13. Levine AJ, Harper JM, Ervin CM et al (2001) Serum 25-hydroxyvitamin D, dietary calcium in take, and distal colorectal adenoma risk. Nutr Cancer 39:35–41

    Article  PubMed  CAS  Google Scholar 

  14. Peters U, McGlynn KA, Chatterjee N et al (2001) Vitamin D, calcium, and vitamin D receptor polymorphism in colorectal adenomas. Cancer Epidemiol Biomarkers Prev 10:1267–1274

    PubMed  CAS  Google Scholar 

  15. Platz EA, Hankinson SE, Hollis BW et al (2000) Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and adenomatous polyps of the distal colorectum. Cancer Epidemiol Biomarkers Prev 9:1059–1065

    PubMed  CAS  Google Scholar 

  16. Grau MV, Baron JA, Sandler RS et al (2003) Vitamin D, calcium supplementation, and colorectal adenomas: results of a randomized trail. J Natl Cancer Inst 95:1765–1771

    Article  PubMed  CAS  Google Scholar 

  17. Braun MM, Helzlsouer KJ, Hollis BW et al (1995) Prostate cancer and prediagnostic levels of serum vitamin D metabolites (Maryland, United States). Cancer Causes Control 6:235–239

    Article  PubMed  CAS  Google Scholar 

  18. Wactawski-Wende J, Kotchen JM, Anderson GL et al (2006) Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med 354:684–696

    Article  PubMed  CAS  Google Scholar 

  19. Gorham ED, Garland CF, Garland FC et al (2007) Optimal vitamin D status for colorectal cancer prevention. A quantitative meta analysis. Am J Prev Med 32:210–216

    Article  PubMed  Google Scholar 

  20. Wu K, Feskanich D, Fuchs CS et al (2007) A nested case–control study of plasma 25-hydroxyvitamin D concentrations and risk of colorectal cancer. J Natl Cancer Inst 99:1120–1129

    Article  PubMed  CAS  Google Scholar 

  21. Otani T, Iwasaki M, Sasazuki S et al (2007) Plasma vitamin D and risk of colorectal cancer: the Japan Public Health Center-Based Prospective Study. Br J Cancer 97:446–451

    Article  PubMed  CAS  Google Scholar 

  22. Freedman DM, Looker AC, Chang SC et al (2007) Prospective study of serum vitamin D and cancer mortality in the United States. J Natl Cancer Inst 99:1594–1602

    Article  PubMed  CAS  Google Scholar 

  23. Peters U, Hayes RB, Chatterjee N et al (2004) Circulating vitamin D metabolites, polymorphism in vitamin D receptor, and colorectal adenoma risk. The Prostate, Lung, Colorectal and Ovarian Cancer Screening Project Team. Cancer Epidemiol Biomarkers Prev 13:546–552

    PubMed  CAS  Google Scholar 

  24. Giovannucci E, Liu Y, Rimm EB, et al (2007) Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst 2006 98:451–459

    Google Scholar 

  25. Garland C, Shekelle RB, Barrett-Conner E et al (1985) Dietary vitamin D and calcium and risk of colorectal cancer: a 19-year prospective study in men. Lancet 1:307–309

    Article  PubMed  CAS  Google Scholar 

  26. Kearney J, Giovannucci E, Rimm EB et al (1996) Calcium, vitamin D and dairy foods and the occurrence of colon cancer in men. Am J Epidemiol 143:907–917

    PubMed  CAS  Google Scholar 

  27. Bostick RM, Potter JD, Sellers TA et al (1993) Relation of calcium, vitamin D, and dairy food intake to incidence of colon cancer in older women. Am J Epidemiol 137:1302–1317

    PubMed  CAS  Google Scholar 

  28. Martinez ME, Giovannucci EL, Colditz GA et al (1996) Calcium, vitamin D, and the occurrence of colorectal cancer among women. J Natl Cancer Inst 88:1375–1382

    Article  PubMed  CAS  Google Scholar 

  29. Zheng W, Anderson KE, Kushi LH et al (1998) A prospective cohort study of intake of calcium, vitamin D, and other micronutrients in relation to incidence of rectal cancer among postmenopausal women. Cancer Epidemiol Biomarkers Prev 7:221–225

    PubMed  CAS  Google Scholar 

  30. Jarvinen R, Knekt P, Hakulinen T et al (2001) Prospective study on milk products, calcium and cancers of the colon and rectum. Eur J Clin Nutr 55:1000–1007

    Article  PubMed  CAS  Google Scholar 

  31. McCullough ML, Robertson AS, Rodriguez C et al (2003) Calcium, vitamin D, dairy products, and risk of colorectal cancer in the cancer prevention study II nutrition cohort (United States). Cancer Causes Control 14:1–12

    Article  PubMed  Google Scholar 

  32. Heilbrun LK, Nomura A, Hankin JH et al (1985) Dietary vitamin D and calcium and risk of colorectal cancer (letter). Lancet 1:925

    Article  PubMed  CAS  Google Scholar 

  33. Benito E, Stiggelbout A, Bosch FX et al (1991) Nutritional factors in colorectal cancer risk: a case–control study in Majorca. Int J Cancer 49:161–167

    Article  PubMed  CAS  Google Scholar 

  34. Peters RK, Pike MC, Garabrandt D et al (1992) Diet and colon cancer in Los Angeles County, California. Cancer Causes Control 3:457–473

    Article  PubMed  CAS  Google Scholar 

  35. Ferraroni M, La Vecchia C, D’Avanzo B et al (1994) Selected micronutrient intake and the risk of colorectal cancer. Br J Cancer 70:1150–1155

    Article  PubMed  CAS  Google Scholar 

  36. Boutron MC, Faivre J, Marteau P et al (1996) Calcium, phosphorus, vitamin D, dairy products and colorectal carcinogenesis: a French case–control study. Br J Cancer 74:145–151

    Article  PubMed  CAS  Google Scholar 

  37. Pritchard RS, Baron JA, Gerhardsson de Verdier M (1996) Dietary calcium, vitamin D, and the risk of colorectal cancer in Stockholm, Sweden. Cancer Epidemiol Biomarkers Prev 5:897–900

    PubMed  CAS  Google Scholar 

  38. Marcus PM, Newcomb PA (1998) The association of calcium and vitamin D, and colon and rectal cancer in Wisconsin women. Int J Epidemiol 27:788–793

    Article  PubMed  CAS  Google Scholar 

  39. Kampman E, Slattery ML, Caan B et al (2000) Calcium, vitamin D, sunshine exposures, dairy products and colon cancer risk (United States). Cancer Causes Control 11:459–466

    Article  PubMed  CAS  Google Scholar 

  40. Park SY, Murphy SP, Wilkens LR et al (2007) Calcium, vitamin D, and dairy product intake and prostate cancer risk: the Multiethnic Cohort Study. Am J Epidemiol 166:1259–1269

    Article  PubMed  Google Scholar 

  41. Freedman DM, Dosemeci M, McGlynn K (2002) Sunlight and mortality from breast, ovarian, colon, prostate, and non-melanoma skin cancer: a composite death certificate based case–control study. Occup Environ Med 59:257–262

    Article  PubMed  CAS  Google Scholar 

  42. Ding EL, Mehta S, Fawzi WW et al (2008) Interaction of estrogen therapy with calcium and vitamin D supplementation on colorectal cancer risk: reanalysis of Women’s Health Initiative randomized trial. Int J Cancer 122:1690–1694

    Article  PubMed  CAS  Google Scholar 

  43. Schwartz GG, Hanchette CL (2006) UV latitude, and spatial trends in prostate cancer mortality: all sunlight is not the same (United States). Cancer Causes Control 17:1091–1101

    Article  PubMed  Google Scholar 

  44. Corder EH, Guess HA, Hulka BS et al (1993) Vitamin D and prostate cancer: a prediagnostic study with stored sera. Cancer Epidemiol Biomarkers Prev 2:467–472

    PubMed  CAS  Google Scholar 

  45. Gann PH, Ma J, Hennekens CH et al (1996) Circulating vitamin D metabolites in relation to subsequent development of prostate cancer. Cancer Epidemiol Biomarkers Prev 5:121–126

    PubMed  CAS  Google Scholar 

  46. Nomura AM, Stemmermann GN, Lee J et al (1998) Serum vitamin D metabolite levels and the subsequent development of prostate cancer. Cancer Causes Control 9:425–432

    Article  PubMed  CAS  Google Scholar 

  47. Platz EA, Leitzmann MF, Hollis BW et al (2004) Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and subsequent risk of prostate cancer. Cancer Causes Control 15:255–265

    Article  PubMed  Google Scholar 

  48. Jacobs ET, Giuliano AR, Martinez ME et al (2004) Plasma levels of 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D and the risk of prostate cancer. J Steroid Biochem Mol Biol 89–90:533–537

    Article  PubMed  Google Scholar 

  49. Ahonen MH, Tenkanen L, Teppo L et al (2000) Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland). Cancer Causes Control 11:847–852

    Article  PubMed  CAS  Google Scholar 

  50. Tuohimaa P, Tenkanen L, Ahonen M et al (2004) Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: a longitudinal, nested case–control study in the Nordic countries. Int J Cancer 108:104–108

    Article  PubMed  CAS  Google Scholar 

  51. Li H, Stampfer MJ, Hollis BW et al (2007) A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer. PLoS Med 4:e103

    Article  PubMed  Google Scholar 

  52. Ahn J, Peters U, Albanes D et al (2008) Serum vitamin D concentration and prostate cancer risk: a nested case–control study. J Natl Cancer Inst 100:796–804

    Article  PubMed  CAS  Google Scholar 

  53. Giovannucci E, Rimm EB, Wolk A et al (1998) Calcium and fructose intake in relation to risk of prostate cancer. Cancer Res 58:442–447

    PubMed  CAS  Google Scholar 

  54. Chan JM, Giovannucci E, Andersson SO et al (1998) Dairy products, calcium, phosphorous, vitamin D, and risk of prostate cancer. Cancer Causes Control 9:559–566

    Article  PubMed  CAS  Google Scholar 

  55. Chan JM, Pietinen P, Virtanen M et al (2000) Diet and prostate cancer risk in a cohort of smokers, with a specific focus on calcium and phosphorus (Finland). Cancer Causes Control 11:859–867

    Article  PubMed  CAS  Google Scholar 

  56. Kristal AR, Cohen JH, Qu P et al (2002) Associations of energy, fat, calcium, and vitamin D with prostate cancer risk. Cancer Epidemiol Biomarkers Prev 11:719–725

    PubMed  CAS  Google Scholar 

  57. John EM, Dreon DM, Koo J et al (2004) Residential sunlight exposure is associated with a decreased risk of prostate cancer. J Steroid Biochem Mol Biol 89–90:549–552

    Article  PubMed  Google Scholar 

  58. John EM, Schwartz GG, Koo J et al (2005) Sun exposure, vitamin D receptor gene polymorphisms, and risk of advanced prostate cancer. Cancer Res 65:5470–5479

    Article  PubMed  CAS  Google Scholar 

  59. Luscombe CJ, Fryer AA, French ME et al (2001) Exposure to ultraviolet radiation: association with susceptibility and age at presentation with prostate cancer. Lancet 358:641–642

    Article  PubMed  CAS  Google Scholar 

  60. Bodiwala D, Luscombe CJ, French ME et al (2003) Associations between prostate cancer susceptibility and parameters of exposure to ultraviolet radiation. Cancer Lett 200:141–148

    Article  PubMed  CAS  Google Scholar 

  61. Rukin N, Blagojevic M, Luscombe CJ et al (2007) Associations between timing of exposure to ultraviolet radiation, T-stage and survival in prostate cancer. Cancer Detect Prev 31(6):443–449

    Article  PubMed  Google Scholar 

  62. Colston KW, Lowe LC, Mansi JL et al (2006) Vitamin D status and breast cancer risk. Anticancer Res 26:2573–2580

    PubMed  CAS  Google Scholar 

  63. Palmieri C, MacGregor T, Girgis S et al (2006) Serum 25-hydroxyvitamin D levels in early and advanced breast cancer. J Clin Pathol 59:1334–1336

    Article  PubMed  CAS  Google Scholar 

  64. Bertone-Johnson E, Chen WY, Holick MF et al (2005) Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 14:1991–1997

    Article  PubMed  CAS  Google Scholar 

  65. Freedman DM, Chang SC, Falk RT et al (2008) Serum levels of vitamin D metabolites and breast cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomarkers Prev 17:889–894

    Article  PubMed  CAS  Google Scholar 

  66. Gissel T, Rejnmark L, Mosekilde L et al (2008) Intake of vitamin D and risk of breast cancer: a meta-analysis. J Steroid Biochem Mol Biol Jun 11 (Epub ahead of print)

    Google Scholar 

  67. Shin MH, Holmes MD, Hankinson SE et al (2002) Intake of dairy products, calcium, and vitamin D and risk of breast cancer. J Natl Cancer Inst 94:1301–1310

    Article  PubMed  CAS  Google Scholar 

  68. Laden F, Spiegelman D, Neas LM et al (1997) Geographic variation in breast cancer incidence rates in a cohort of U.S. women. J Natl Cancer Inst 89:1373–1378

    Article  PubMed  CAS  Google Scholar 

  69. John EM, Schwartz GG, Dreon DM et al (1999) Vitamin D and breast cancer risk: the NHANES I Epidemiologic follow-up study, 1971–1975 to 1992. National Health and Nutrition Examination Survey. Cancer Epidemiol Biomarkers Prev 8:399–406

    PubMed  CAS  Google Scholar 

  70. John EM, Schwartz GG, Koo J et al (2007) Sun exposure, vitamin D receptor gene polymorphisms, and breast cancer risk in a multiethnic population. Am J Epidemiol 166:1409–1419

    Article  PubMed  Google Scholar 

  71. Knight JA, Lesosky M, Barnett H et al (2007) Vitamin D and reduced risk of breast cancer: a population-based case–control study. Cancer Epidemiol Biomarkers Prev 16:422–429

    Article  PubMed  CAS  Google Scholar 

  72. Stolzenberg-Solomon RZ, Vieth R, Azad A et al (2006) A prospective nested case–control study of vitamin D status and pancreatic cancer risk in male smokers. Cancer Res 66:10213–10219

    Article  PubMed  CAS  Google Scholar 

  73. Giovannucci E, Liu Y, Rimm EB et al (2006) Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst 98:451–459

    Article  PubMed  CAS  Google Scholar 

  74. Skinner HG, Michaud DS, Giovannucci E et al (2006) Vitamin D intake and the risk for pancreatic cancer in two cohort studies. Cancer Epidemiol Biomarkers Prev 15:1688–1695

    Article  PubMed  CAS  Google Scholar 

  75. Chen W, Dawsey SM, Qiao YL et al (2007) Prospective study of serum 25(OH)-vitamin D concentration and risk of oesophageal and gastric cancers. Br J Cancer 97:123–128

    Article  PubMed  CAS  Google Scholar 

  76. Abnet CC, Chen W, Dawsey SM et al (2007) Serum 25(OH)-vitamin D concentration and risk of esophageal squamous dysplasia. Cancer Epidemiol Biomarkers Prev 16:1889–1893

    Article  PubMed  CAS  Google Scholar 

  77. Tworoger SS, Lee IM, Buring JE et al (2007) Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of incident ovarian cancer. Cancer Epidemiol Biomarkers Prev 16:783–788

    Article  PubMed  CAS  Google Scholar 

  78. Kricker A, Armstrong BK, Hughes AM et al (2008) Personal sun exposure and risk of non Hodgkin lymphoma: a pooled analysis from the Interlymph Consortium. Int J Cancer 122:144–154

    Article  PubMed  CAS  Google Scholar 

  79. Freedman DM, Zahm SH, Dosemeci M (1997) Residential and occupational exposure to sunlight and mortality from non-Hodgkin’s lymphoma: composite (threefold) case–control study. BMJ 314:1451–1455

    Article  PubMed  CAS  Google Scholar 

  80. Pilz S, Dobnig H, Winklhofer-Roob B et al (2008) Low serum levels of 25-hydroxyvitamin D predict fatal cancer in patients referred to coronary angiography. Cancer Epidemiol Biomarkers Prev 17:1228–1233

    Article  PubMed  CAS  Google Scholar 

  81. Ducloux D, Courivaud C, Bamoulid J et al (2008) Pretransplant serum vitamin D levels and risk of cancer after renal transplantation. Transplantation 85:1755–1759

    Article  PubMed  CAS  Google Scholar 

  82. Trivedi DP, Doll R, Khaw KT (2003) Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomized double blind controlled trial. BMJ 326:469–475

    Article  PubMed  CAS  Google Scholar 

  83. Lappe JM, Travers-Gustafson D, Davies KM et al (2007) Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr 85:1586–1591

    PubMed  CAS  Google Scholar 

  84. Whitlatch LW, Young MV, Schwartz GG et al. (2002) 25-Hydroxyvitamin D-1alpha-hydroxylase activity is diminished in human prostate cancer cells and is enhanced by gene transfer. J Steroid Biochem Mol Biol 81:135–140

    Article  PubMed  CAS  Google Scholar 

  85. Chen TC, Wang L, Whitlatch LW et al (2003) Prostatic 25-hydroxyvitamin D-1alpha-hydroxylase and its implication in prostate cancer. J Cell Biochem 88:315–322

    Article  PubMed  CAS  Google Scholar 

  86. Porojnicu A, Robsahm TE, Berg JP et al (2007) Season of diagnosis is a predictor of cancer survival. Sun-induced vitamin D may be involved: a possible role of sun-induced Vitamin D. J Steroid Biochem Mol Biol 103:675–678

    Article  PubMed  CAS  Google Scholar 

  87. Ng K, Meyerhardt JA, Wu K et al (2008) Circulating 25-hydroxyvitamin D levels and survival in patients with colorectal cancer. J Clin Oncol 26:2984–1991

    Google Scholar 

  88. Zhou W, Heist RS, Liu G et al (2007) Circulating 25-hydroxyvitamin D levels predict survival in early-stage non-small-cell lung cancer patients. J Clin Oncol 25:479–485

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Nutrition, Epidemiology, Harvard School of Public Health, Boston, MA, 02115, USA

    Edward Giovannucci MD, SCD

  2. Channing Laboratory, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, 02115, USA

    Edward Giovannucci MD, SCD

Authors
  1. Edward Giovannucci MD, SCD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. East Newton St. 85, Boston, 02118, Massachusetts, USA

    Michael F. Holick

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Giovannucci, E. (2010). The Epidemiology of Vitamin D and Cancer Risk. In: Holick, M. (eds) Vitamin D. Nutrition and Health. Humana Press. https://doi.org/10.1007/978-1-60327-303-9_42

Download citation

  • DOI: https://doi.org/10.1007/978-1-60327-303-9_42

  • Published:

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-60327-300-8

  • Online ISBN: 978-1-60327-303-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation